Dental Cement Market Size and Share
Market Overview
| Study Period | 2020 - 2031 |
|---|---|
| Forecast Data Period | 2026 - 2031 |
| Market Size (2026) | USD 1.63 Billion |
| Market Size (2031) | USD 2.14 Billion |
| Growth Rate (2026 - 2031) | 5.62% CAGR |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players *Disclaimer: Major Players sorted in no particular order Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0. | |
Dental Cement Market Analysis by Mordor Intelligence
Dental cement market size in 2026 is estimated at USD 1.63 billion, growing from 2025 value of USD 1.54 billion with 2031 projections showing USD 2.14 billion, growing at 5.62% CAGR over 2026-2031. Momentum stems from a confluence of demographic pressures, rising procedural volumes, and technological progress in bio-active and nano-hybrid formulations that improve longevity and aesthetics. The European Union’s mercury amalgam ban, effective January 2025, has triggered rapid substitution toward fluoride-releasing, mercury-free cements and similar legislation is proliferating in other regions. Digital workflows in CAD/CAM and 3-D printing continue to widen the indications for advanced cement systems, while artificial intelligence is refining material selection and placement protocols. Supply-chain friction in specialty monomers and rare-earth fillers poses a headwind, yet manufacturers with diversified sourcing and validated regulatory dossiers maintain pricing power in premium segments.
Key Report Takeaways
- By type, permanent cements led with 71.80% of the dental cement market share in 2025, whereas temporary cements are projected to advance at a 6.15% CAGR through 2031.
- By material, glass ionomer captured 31.05% revenue share in 2025; bio-active resin cements are forecast to expand at a 6.95% CAGR to 2031.
- By application, restorations accounted for a 38.90% share of the dental cement market size in 2025; surgical dressing applications show the fastest growth at an 7.65% CAGR through 2031.
- By geography, North America commanded 39.05% of the dental cement market share in 2025, while Asia-Pacific is progressing at a 6.90% CAGR to 2031.
Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of 2026.
Global Dental Cement Market Trends and Insights
Drivers Impact Analysis*
| Driver | % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Rising prevalence of dental caries and edentulism | +1.2% | Global, with higher impact in Asia-Pacific and Latin America | Medium term (2-4 years) |
| Increasing orthodontic & prosthodontic procedure volumes | +1.0% | North America & Europe core, expanding to Asia-Pacific | Long term (≥ 4 years) |
| Growth of cosmetic / aesthetic dentistry | +0.8% | North America & Europe, emerging in urban Asia-Pacific | Medium term (2-4 years) |
| Regulatory push toward mercury-free, fluoride-releasing restoratives | +1.5% | Europe immediate, North America following, Global adoption | Short term (≤ 2 years) |
| Rapid emergence of bio-active & nano-hybrid cement technologies | +0.9% | Global, with early adoption in developed markets | Long term (≥ 4 years) |
| Source: Mordor Intelligence | |||
Rising Prevalence of Dental Caries and Edentulism
Untreated dental caries affected nearly 3.5 billion people in 2024, establishing a persistent clinical workload that sustains the dental cement market. Aging demographics elevate edentulism rates and heighten demand for durable prosthodontic solutions that rely on high-strength permanent cements. The global economic burden—USD 387 billion in direct costs and USD 323 billion in indirect costs—reinforces the need for cements that minimize retreatment cycles. Manufacturers that demonstrate bio-activity, fluoride release, and simplified workflows strengthen adoption among cost-sensitive providers within the dental cement market.
Increasing Orthodontic & Prosthodontic Procedure Volumes
Surveys indicate 20.6% of young adults intend to pursue aligner therapy, intensifying demand for cements compatible with ceramic brackets and clear-aligner attachments. Prosthodontics is scaling as CAD/CAM and 3-D printing shorten chair time and elevate aesthetics, driving need for cements that bond to zirconia, lithium-disilicate, and polymer-infiltrated ceramics. Integration of robotics and AI in prosthodontics raises performance benchmarks for bond strength and marginal integrity. These factors reinforce long-term demand trajectories in the dental cement market.
Growth of Cosmetic / Aesthetic Dentistry
Social-media visibility and remote communication motivate elective cosmetic treatments, broadening restorative volumes that hinge on color-stable, translucent cements. Digital intraoral scanning and 3-D printing permit one-visit indirect restorations, catalyzing uptake of dual-cure, low-shrinkage cements with simplified cleanup. Dental service organizations, expected to reach 39% of U.S. practices by 2026, standardize procurement and favor suppliers offering consistent performance across multi-state locations. Bulk-fill composites require companion luting agents that resist marginal discoloration; universal bio-active cements address this gap and elevate brand differentiation within the dental cement market.
Regulatory Push Toward Mercury-Free, Fluoride-Releasing Restoratives
The EU ban eliminates roughly 40 tonnes of dental mercury annually, forcing clinicians to migrate to bio-compatible cements with demonstrable fluoride[1]Source: European Commission, “Revised Mercury Regulation Enters into Force,” environment.ec.europa.eu. The Minamata Convention extends pressure globally as regulators scrutinize amalgam alternatives. Glass ionomer and resin-modified glass ionomer cements stand to benefit owing to chemical adhesion and antimicrobial properties. Manufacturers fast-tracking smart ion-releasing matrices gain early mover advantage in the dental cement market.
Restraints Impact Analysis*
| Restraint | % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| High price sensitivity among small dental clinics | -0.7% | Global, with higher impact in emerging markets | Medium term (2-4 years) |
| Stringent ISO 4049 & FDA 510(k) performance validations | -0.5% | Global regulatory compliance requirements | Long term (≥ 4 years) |
| Supply-chain crunch in specialty monomers & rare-earth fillers | -0.6% | Global, with concentrated supplier dependencies | Short term (≤ 2 years) |
| Environmental scrutiny on eugenol & Bis-GMA disposal | -0.3% | Europe & North America primarily | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
High Price Sensitivity Among Small Dental Clinics
Ninety-five percent of independent practices reported higher supply costs in 2024, while hygienist wages increased 26.6% between 2018 and 2023, eroding margins. These clinics often substitute premium bio-active cements with lower-cost alternatives, slowing penetration in price-elastic regions. Insurance reimbursement ceilings exacerbate procurement trade-offs, prompting practices to evaluate total cost of care when selecting cement systems. In emerging markets, the dynamic limits volume growth for advanced formulations, moderating overall expansion in the dental cement market.
Stringent ISO 4049 & FDA 510(k) Performance Validations
Compliance with ISO 4049, ANSI/ADA, and expanded FDA guidance extends product-development lead times and increases validation expenses[2]Source: U.S. Food and Drug Administration, “Dental Composite Resin Devices and Dental Curing Lights—Premarket Notification (510(k)) Submissions,” federalregister.gov. The Safety and Performance Based Pathway still requires substantial equivalence, favoring entrenched brands with large clinical datasets. Smaller innovators encounter funding and resource constraints, limiting the pipeline of novel materials entering the dental cement market.
*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.
Segment Analysis
By Type: Permanent Dominance Drives Market Stability
Permanent products held 71.80% of the dental cement market share in 2025, anchoring overall revenue due to their role in definitive crowns, bridges, and implant restorations. Enhanced bio-active formulations such as ACTIVA BioACTIVE release fluoride, calcium, and phosphate ions, promoting remineralization and mitigating secondary caries risk. Universal self-adhesive chemistries simplify clinical workflows by eliminating separate primers, reducing chair time for high-volume practices.
Temporary cements, although smaller in revenue, are forecast to expand at a 6.15% CAGR as multi-stage implant cases and complex rehabilitations proliferate. Demand is further buoyed by the rise of same-day CAD/CAM workflows that use temporary restorations for occlusal verification before final placement. Innovations in eugenol-free, resin-reinforced temporary cements improve stability without compromising retrievability, enhancing patient experience and clinic efficiency within the dental cement market.
By Material: Glass Ionomer Leadership Faces Bio-Active Challenge
Glass ionomer maintained 31.05% revenue leadership in 2025 owing to chemical adhesion and sustained fluoride release that supports caries prevention. Smart response additives now tailor ion release to pH fluctuations, extending preventive benefits.
Bio-active resin cements record the fastest 6.95% CAGR, combining high flexural strength with aesthetics demanded in anterior restorations. Nanofiller incorporation reduces polymerization shrinkage and improves translucency, aligning with cosmetic dentistry trends. Zinc-oxide eugenol and zinc-phosphate remain for pulpal protection and specialty uses, while research into phosphoric-slag-enhanced zinc phosphate aims to upgrade mechanical properties at competitive cost. Emerging calcium-silicate formulations and nano-hybrids widen the materials palette and intensify competition in the dental cement market.
By Application: Restorations Segment Anchors Market Growth
Restorations represented 38.90% of 2025 revenue, reflecting dependence on cements for indirect fixed prostheses and inlays/onlays. Dual-cure, low-film-thickness cements improve marginal fit for CAD/CAM restorations and extend indications to posterior load-bearing cases. Universal adhesive systems such as G-CEM ONE bond to metal, zirconia, and lithium-disilicate without separate primers, supporting streamlined digital workflows.
Surgical dressing applications advance at an 7.65% CAGR due to bio-active cements applied in endodontic and periodontal surgeries. Calcium silicate-based materials provide sealing and regenerative properties, broadening cement usage beyond traditional luting. Luting and bonding progress in tandem with the proliferation of high-translucency zirconia, whereas pulpal protection remains stable yet benefits from bioceramic upgrades that enhance vital pulp therapy outcomes in the dental cement market.
Geography Analysis
North America led with 39.05% of the dental cement market share in 2025, underpinned by advanced dental infrastructure, high insurance penetration, and widespread adoption of digital dentistry. Expansion of dental service organizations is standardizing procurement protocols and accelerating uptake of premium bio-active systems. Regulatory clarity provided by FDA 510(k) pathways, despite added stringency, encourages early commercial launches, particularly for universal adhesive and dual-cure products.
Asia-Pacific delivers the fastest 6.90% CAGR, propelled by growing middle-class populations and heightened awareness campaigns. India hosts roughly 65,000 dental clinics and a USD 1.7 billion dental ecosystem, fuelling demand for restorative materials that balance performance with affordability. China’s rapid urbanization raises restorative procedure volumes, while Japan and South Korea contribute through advanced materials innovation and insurance support for geriatric care. Nonetheless, price sensitivity dictates tiered portfolio strategies as clinics weigh premium features against budget constraints in the dental cement market.
Europe confronts immediate material transition challenges following the January 2025 mercury amalgam ban, instigating accelerated adoption of mercury-free, fluoride-releasing cements environment. Germany, France, and the United Kingdom spearhead demand given robust prosthodontic training programs and consumer preference for aesthetic treatments. Regulatory harmonization via ISO 106 dentistry standards elevates product quality thresholds, favoring manufacturers with documented biocompatibility and long-term clinical data.
Regulatory Landscape
Dental cements are primarily regulated as medical devices, with many products cleared through Class II pathways in the United States under 21 CFR Part 872 (including dental cement classifications such as 21 CFR 872.3275). Performance and safety substantiation commonly align to FDA-recognized consensus standards, including ISO 9917-1 for water-based (acid-base) dental cements, alongside related standards such as ISO 3107 for zinc oxide-eugenol cements and ISO 10993 for biological evaluation.
Recent compliance changes add complexity for products that incorporate medicinal agents and can be treated as combination products under 21 CFR Part 3, where oversight interactions involve FDA's Office of Combination Products. In June 2025, FDA issued draft guidance on Unique Device Identifier (UDI) requirements for combination products with device constituent parts, increasing labeling and traceability expectations for cement systems that bundle device and drug/biologic elements across global supply chains.
Value Chain Analysis
The dental cement value chain begins with upstream inputs such as specialty monomers, glass powders, metallic additives, and fillers, followed by compounding and high-precision processing to meet film thickness and handling specifications, including tight particle-size control to support thin film thickness for luting. Manufacturing then proceeds through packaging formats (powder-liquid, paste-paste, dual-barrel syringes) and extensive in-process and release testing against standards such as ISO 9917-1 and FDA-recognized consensus standards, supported by biocompatibility evaluation under ISO 10993 and regional quality system requirements.
Downstream, producers such as 3M (now with Solventum positioned around the RelyX franchise), Dentsply Sirona, Ivoclar, GC Corporation, and Kuraray Noritake supply dental distributors and, increasingly, dental service organization (DSO) procurement channels that emphasize consistency and workflow compatibility. Supply-chain friction persists around specialty monomers and rare-earth or advanced fillers, making supplier qualification, moisture-controlled logistics, and documentation readiness important differentiators for manufacturers serving multi-country portfolios under frameworks such as the EU Medical Device Regulation (MDR 2017/745).
Competitive Landscape
The dental cement market is moderately concentrated, with incumbents leveraging patent portfolios, clinical validation, and global distribution. Solventum’s spin-off from 3M positions the RelyX franchise for focused investment and agile product cycles. Dentsply Sirona’s Essential Dental Solutions division prioritizes universal resin cements within its restorative workflow ecosystem, supported by DS Academy educational programs. GC Corporation capitalizes on Smart Response Ion Technology to defend leadership in glass-ionomer hybrids, while regional brands such as Kuraray Noritake and Ivoclar focus on high-translucency cement systems for aesthetic ceramics.
Strategic alliances extend reach, exemplified by Young Specialties–BISCO–Torch Dental collaboration to streamline procurement for multisite practices. Private-equity activity exceeded USD 9 billion in 2024, funding portfolio additions in bio-active and nano-hybrid technologies. Supply-chain resilience, especially in rare-earth fillers, is emerging as a competitive differentiator as manufacturers diversify sourcing to mitigate geopolitical risks.
Marketing strategies increasingly emphasize evidence-based efficacy and digital workflow compatibility. Award recognitions, such as Dental Advisor’s 2024 Preferred Product Award for NX3 Nexus Third Generation, bolster brand prestige. Customer-centric service packages—training, software integration, and outcome tracking—support differentiation beyond baseline material properties, sustaining competitive intensity in the dental cement market.
Dental Cement Industry Leaders
Dentsply Sirona
Ivoclar Vivadent AG
BISCO Inc.
Shofu Dental Corporation
3M
- *Disclaimer: Major Players sorted in no particular order
Market Opportunities and Future Outlook
Material transition away from mercury-based restoratives is expanding whitespace for fluoride-releasing and mercury-free cement systems, particularly in Europe following the January 2025 mercury amalgam ban and the broader influence of the Minamata Convention. This supports demand for glass ionomer, resin-modified glass ionomer, and bio-active resin cements that combine adhesion, esthetics, and preventive ion release, while also raising the value of ISO-aligned performance evidence (for example, ISO 9917-1:2025, published in May 2025) and technical dossiers capable of supporting multi-region commercialization.
Workflow simplification and restorative system integration are also creating opportunity pockets for universal, self-adhesive resin cements that reduce steps across zirconia and lithium-disilicate indications and align with chairside CAD/CAM. Recent actions reinforce this direction, including COLTENE's March 2026 launch of SoloCem (universal self-adhesive resin cement) and Mitsui Chemicals' June 2026 announced acquisition of Ultradent Products to expand global dental materials capabilities, signaling continued emphasis on scale, distribution reach, and coordinated materials ecosystems across restorations and cementation.
Recent Industry Developments
- June 2026: Mitsui Chemicals announced the acquisition of Ultradent Products Inc. to expand its global dental materials capabilities. The deal broadens access to established distribution and clinical relationships, supporting wider commercialization of restorative consumables, including cement-adjacent systems used in indirect workflows.
- August 2025: Dentsply Sirona launched Calibra Abutment Resin Cement for extraoral cementation of crowns or abutments to TiBase in implant workflows. It strengthens the company's system approach that pairs CAD/CAM materials and abutment components with corresponding cementation protocols for more consistent outcomes.
- September 2024: Henry Schein gained exclusive DSO distribution rights for Curodont Repair Fluoride Plus. The agreement strengthens channel access to fluoride-oriented minimally invasive restorative offerings and increases competitive pressure on cement and restorative suppliers targeting standardized DSO procurement.
Research Methodology Framework and Report Scope
Market Definition and Coverage
This market covers ready-to-use dental cements used in dental procedures to bond, seal, or line teeth and indirect restorations in chair-side clinical settings. It includes common formulation families supplied as powders, pastes, or dual-barrel syringes that are purchased and used by dental care providers.
Scope exclusions: This sizing excludes bulk restorative composites, temporary luting pastes mainly used for laboratory models, and adhesives used only for digital impression trays.
Segmentation Overview
- By Type
- Permanent
- Temporary
- By Material
- Zinc-Oxide Eugenol
- Zinc Phosphate
- Polycarboxylate
- Glass Ionomer
- Resin-Based
- Others
- By Application
- Pulpal Protection
- Luting & Bonding
- Restorations
- Surgical Dressing
- By Geography
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
- South America
- Brazil
- Argentina
- Rest of South America
- North America
Data Sources, Market Sizing, and Validation
Desk Research
Desk work was used to set the practical boundaries of what counts as dental cement, and then to build the basic demand and supply context by geography. We relied on public and official sources such as oral health burden and care access publications from the World Health Organization, health statistics releases from sources such as the US CDC, and health expenditure datasets from sources such as the World Bank and OECD.
To keep the model grounded in how products flow and get used, we also reviewed sources such as national dental association guidance, peer-reviewed dentistry journals on cement use in crowns and bridges, and regulatory or standards references for dental materials where available. Company annual reports, investor presentations, and reputable press were reviewed to cross-check pricing direction and shifts toward resin and glass ionomer families. In a few places, paid subscriptions supporting company financials and patent landscaping were used to speed up fact checks and confirm timing of product-change cycles. These examples are illustrative only, and many additional sources were consulted for data collection, validation, and clarification.
Primary Interviews and Surveys
Primary interviews were used to test assumptions that desk sources do not fully resolve, especially which procedures drive consumption and how cement choice changes with clinical preference and reimbursement pressure. We spoke with manufacturers, distributors, dental clinic procurement teams, and practicing dentists across major regions, focusing on gaps around utilization rates, typical pack sizes, and price movement so the final model reflected real buying behavior.
Distribution of primary research fieldwork respondents
| Company type | Respondent position | Region |
|---|---|---|
| Top tier: 29% | CXOs: 18% | APAC: 37% |
| Mid tier: 53% | Functional/Unit leaders: 35% | EMEA: 36% |
| Smaller Players: 18% | Managers: 47% | Americas: 27% |
Market-Sizing & Forecasting
Sizing starts with a top-down reconstruction of the addressable demand pool using procedure-led consumption logic, where the number of indirect restorations and related cemented procedures is translated into cement volumes and then into value using realistic price bands. Because each cement family is used differently, assumptions were split across indicators such as crown and bridge placement volumes, orthodontic bonding activity, the mix shift between conventional and resin-based cements, average cement usage per procedure (including waste), and inflation-adjusted pricing trends by region.
Results were then checked using selective bottom-up approximations, including rolling up a sample of supplier revenues tied to dental cement portfolios and validating channel feedback on annual unit movement. Where direct shipment or revenue signals were incomplete for smaller countries, we filled gaps with proxy variables like dental visit rates and dentist density, and then normalized the outputs to known healthcare spending and import patterns. For forecasting, scenario analysis was used, with year-by-year procedure growth, pricing progression, and product-mix change as the main levers reviewed with interviewees before the final values were locked.
Data Validation & Update Cycle
Model outputs are checked against independent signals so that any outliers can be investigated before sign-off, including procedure growth direction, regional price movement, and consistency with broader dental consumables spending. When a country result looks unusually high or low, the assumptions are revisited, and follow-up calls are triggered if the variance cannot be explained through a clear demand or pricing change.
A multi-step internal review is followed, where calculations, unit conversions, and currency handling are rechecked and then compared with historical trends to confirm the slope is sensible. Reports are refreshed annually, and interim updates are made when a material event occurs, such as a regulatory change or a sharp input-cost shift. Before delivery, one last analyst pass is completed so clients receive the latest updated view.
Mordor Intelligence's Dental Cement Market Size Compared With Other Published Estimates
Published market sizes for dental cement do not always match because the term is scoped differently across studies, and because procedure counts, pricing, and currency timing are handled in different ways. Differences also come from whether temporary and permanent cements are treated together, and whether the numbers are built from procedure demand or from supplier-side revenue signals.
By tracking procedure volumes and price bands by cement family, and then refreshing currency timing and mix assumptions through Mordor Intelligence cross-check calls, the estimate avoids counting adjacent restorative materials that do not behave like cement in clinic purchasing.
Benchmark comparison
| Source | Market Size | Gaps in Research Methodology |
|---|---|---|
| Mordor Intelligence | USD 1.63 B (2026) | |
| Global Consultancy A | USD 2.10 B (2024) | Uses an earlier base year and a broader product boundary that can bundle some restorative and protective materials alongside cement, which lifts the total versus a chair-side cement only scope. |
| Industry Research Group B | USD 1.36 B (2024) | Applies a narrower demand pool and slower pricing progression, and the forecast window is shorter, which can understate value when resin-based cement adoption and premium mix are rising. |
The spread in values is mostly explained by what gets included in the product boundary, how procedure-led demand is translated into units, and how pricing and currency are updated. When the scope is kept tight to chair-side dental cements and assumptions are tied back to procedure activity and realistic price bands, the market size becomes easier to reproduce and to challenge with clear checks.
Key Questions Answered in the Report
What is the current valuation of the dental cement market?
The dental cement market size stood at USD 1.63 billion in 2026 and is projected to reach USD 2.14 billion by 2031 at a 5.62% CAGR.
Which segment holds the largest share in the dental cement market?
Permanent cements dominated with 71.80% of the dental cement market share in 2025, reflecting their critical role in long-term restorations.
Which material category is growing fastest?
Bio-active resin cements are advancing at a 6.95% CAGR through 2031 as clinicians seek materials that combine high strength, aesthetics, and fluoride release.
Why is Asia-Pacific the fastest-growing region?
Rising middle-class populations, expanding clinic networks, and increasing awareness of oral health are driving a 6.90% CAGR in Asia-Pacific demand for restorative materials.
How is the EU mercury amalgam ban influencing product demand?
The January 2025 ban is accelerating transition toward mercury-free, fluoride-releasing glass ionomer and resin-modified cements across Europe and influencing global policy adoption.
What years does this Dental Cement Market cover, and what was the market size in 2025?
In 2025, the Dental Cement Market size was estimated at USD 1.63 billion. The report covers the Dental Cement Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Dental Cement Market size for years: 2026, 2027, 2028, 2029, 2030 and 2031.
Page last updated on:
